Drooid Logo
Back to story perspectives

Full Breakdown

Ebola Bundibugyo Outbreak in DRC Surpasses Past Cases Amid Detection Gaps and Community Resistance

6/25/2026, 10:48:06 PM

Outbreak Overview

Declared in mid-May 2026, the Democratic Republic of Congo has reported over 1,100 confirmed Bundibugyo Ebola cases and nearly 300 deaths, the largest outbreak of this strain. Uganda has recorded 20 cases and two deaths. The World Health Organization (WHO) leads the response, with emergencies director Chikwe Ihekweazu briefing the media. The International Medical Corps runs treatment centres, and health official Emmanuel Musingusi Bulemu investigates cases in Ituri’s Nizi area. Bundibugyo first emerged in Uganda in 2007 and later in Congo in 2012, and is distinct from the Zaire strain that caused the 2014-2016 West African epidemic.

Data & Statistics

Official tallies list >1,100 cases and ~300 deaths in the DRC, plus 20 cases and two deaths in Uganda. Among 505 confirmed patients, only 10 % bled, versus the CDC’s 40 % estimate. Over half of patients present at an advanced stage.

Challenges & Opposition

Rapid tests target Zaire Ebola, delaying Bundibugyo detection. No licensed vaccine or treatment exists, though trials start next week. Early symptoms mimic malaria, causing delayed care. Residents expect bleeding; the low rate fuels accusations of misinformation, sparking resistance and occasional violence. Conflict in Ituri hampers access, and experts warn peace is needed to contain the outbreak.

Official Statements & Responses

WHO officials say the outbreak is poorly understood and stress testing, isolation and treatment. They note bleeding occurs in only 10 % of cases and call for communication that addresses community expectations. WHO also announced therapeutic trials will begin soon.

Conflicting Reports & Gaps

The CDC estimates 40 % bleeding, while WHO data show 10 %. Lack of Bundibugyo-specific diagnostics and approved vaccines leaves critical gaps.

Verbatim Quotes

  • "We’re facing an outbreak… that we’re just, to be honest, beginning to understand." — Chikwe Ihekweazu, WHO emergencies director
  • "For those at [the] early stage of the disease, it looks milder than Zaire, and I believe that [is] one of the reasons we are seeing more than 50% patients at an advanced stage." — Abdou Sebushishe, senior adviser, International Medical Corps
  • "As a result, people in the community say, 'Before, it was bleeding. We haven't seen any bleeding in our sick relative, so you're lying to us,'" — Emmanuel Musingusi Bulemu, Congolese health official
  • "But I have never seen this many cases this quickly." — Peter Piot, professor, London School of Hygiene and Tropical Medicine

What’s Next

Therapeutic trials for Bundibugyo Ebola begin next week, while WHO and national partners expand surveillance and community engagement. Securing safe access in conflict-affected zones will be decisive for curbing transmission.